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Abstract It was previously demonstrated that secretin
influenced the behavior of rats investigated by open-field
test. In the present experiment, we have compared the
effect of intracerebroventricular administration of 2 μg of
secretin on the behavior of CFLP white and Japanese
waltzing mice. These latter animals exhibit stereotypic
circular movements. The effect of secretin on the
horizontal (ambulation) and vertical movements (rearing
and jumping) was investigated in open-field test. The
ambulation time and distance were shorter, and the
number of rearing and jumping were much lower in
Japanese waltzing mice than in CFLP white mice during
30 min-experimental period. In white mice, 2 μg of
secretin had no effect on the above-mentioned parameters;
however, in Japanese waltzing mice, secretin enhanced the
ambulation time and distance to the level of CFLP white
mice, but did not influence the rearing and jumping. On
the basis of the results, it was concluded that
intracerebroventricularly administered secretin attenuated
the stereotypic (circulating) movement and improved the
horizontal movement indicated by the normalization of the
ambulation time and distance; however, it did not
influence the explorative behavior (rearing and jumping)
in our special animal model.
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Introduction
For a long time, secretin was known to be a gastrointes-
tinal peptide. It was first demonstrated by Bayliss and
Starling (1902) and characterized 60 years later by Jorpes
et al. (1962). The presence of secretin in the nervous
system was first demonstrated by Charlton et al. (1981).
With the use of radioimmunoassay and high pressure
liquid chromatography secretin was found in several
regions of the central nervous system including the
thalamus, hypothalamus, olfactory bulb, cerebral cortex,
midbrain, septum, striatum, hippocampus, medulla, and
the pons. The highest concentration was observed in two
endocrine glands: the pineal body and the pituitary gland.
The expression of the precursor gene was demonstrated in
the medulla, pons, and the pituitary gland (Itoh et al.
1991). Secretin and its mRNA were also shown in the
Purkinje cells of the cerebellar cortex (Yung et al. 2001;
Köves et al. 2002, 2004).
Upcoming data demonstrate that secretin influences
several functions in the nervous system. Intravenous (iv)
infusion of secretin to rats induced c-fos gene expression in
the central amygdala, area postrema, bed nucleus of stria
terminalis (BNST), external lateral parabranchial and the
hypothalamic supraoptic (SO) nucleus (Goulet et al. 2003).
After intracerebroventricular (icv) administration of secretin
many regions such as several brain stem, hypothalamic, and
limbic structures (septum and amygdala) and the medial
bank of the anterior prefrontal, orbitofrontal, and the
piriform cortex showed activation of Fos protein in awake,
freely moving rats (Welch et al. 2003). It is clear from the
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above-mentioned data that secretin influences c-fos expres-
sion in structures that are involved in behavior, stress
adaptation and visceral responses. In the cells of pheochro-
mocytoma cell line, secretin stimulates the activity of thyrosin
hydroxylase, an enzyme important in catecholamine synthesis
(Roskoski et al. 1989). Secretin also induces neurite
outgrowth through cyclic-adenosine monophosphate
(cAMP)-protein kinase pathway (Kim et al. 2006). In rats
its icv administration decreased the open-field locomotor
activity and novel object approach (Charlton et al. 1983). In
the cerebellum secretin facilitates the glutamate and γ-amino
butiric acid (GABA)-ergic inhibitory inputs onto Purkinje
cells via a postsynaptic and cAMP-dependent mechanism as
a retrograde messenger (Yung et al. 2001, 2006). It has also
become evident that secretin is synthetized in the hypotha-
lamic SO and paraventricular (PV) nuclei (Welch et al. 2004)
and it regulates water homeostasis (Chu et al. 2009). In the
PV, there may be an interaction between secretin and
corticotropin hormone-releasing hormone (CRH; Welch and
Ruggiero 2005). More than a decade ago, it was found that
secretin counteracts with the analgesic effect of morphine
(Babarczy et al. 1995).
In the present study, we compared the effect of secretin on
the behavior of two mouse-strains, CFLP white mouse and
Japanese waltzingmouse (JWM). CFLPmice are usually used
for testing the effect of various drugs on the behavior. JWM
were also included because they exhibit a repetitive movement
which is characteristic for several mental disorders. These
animals run around in their cage nearly without stopping. The
main aim of this experiment was to clarify whether icv
administered secretin could influence the stereotypic behavior.
Open-field test was used to investigate the effect of secretin on
the behavior of the animals.
Materials and Methods
Animals
Adult (3–4 month old) CFLP white and JW female mice
were used for the experiments. The animals were kept in a
light- and temperature-controlled vivarium (lights on at
5:00 h and lights off at 19:00 h; temperature 22±2°C).
Treating the animals was in accordance with the rules of the
“European convention for the protection of vertebrate
animals used for experimental and other scientific purpo-
ses”, Strasbourg, 1986; permission #: 37/1999.
Implantation of Guiding Cannula
Under general hexobarbital anesthesia (0.08 mg/gr BW), a
guiding cannula was implanted in the lateral ventricle of 12
CFLP white mice and 10 JWM. A day later, 2 μg secretin
in 2 μl arteficial cerebrospinal fluid was administered
through the cannula. Controls received only cerebrospinal
fluid. We used female mice of both strains. The effect of
secretin on behavior of the animals was examined using an
open-field test. All animals were investigated in the
morning.
Behavior Study
The open-field apparatus was a square open-field black
cage with a side length of 60 cm, surrounded by a 40 cm
high wall. The floor of the cage was divided in 36 (6×6)
small squares. A 60 W light was situated 1 m above the
arena floor. Sessions started at 9 a.m. All animals were
carried to the experimental room in their home cage. Each
animal was placed in the center of the open field and was
observed for 30 min. Conducta 1.0 system (Experimetria
Ltd., Budapest, Hungary) was used for monitoring the
animals and analyzing the data.
The horizontal locomotor activity, defined as ambulation
time and distance, and the vertical activity, rearing and
jumping frequencies, defined as number of times the
animals stood on their hind legs or jumped up, were
evaluated.
Statistical analysis of the data was made by repeated
measure analysis of variance (ANOVA). For significant
ANOVA values, groups were compared by Tukey's test as
post test. A probability value, p<0.05 was considered
statistically significant.
Results
Detailed analysis of the horizontal and vertical movements
revealed the following. In Fig. 1, white lines trace the
movement of animals in the chamber. The horizontal
movement of the control CFLP white mice and the JWM
was basically different. The image demonstrates the
characteristic feature of the movement of the two strains.
The movement of white mice was mainly linear (Fig. 1a);
however, the movement of JWM was circular in many
cases (Fig. 1b). The white mice ran at the periphery of the
arena, they tried to avoid the illuminated center (Fig. 1c).
The motion of the JWM was opposite. They mainly
remained in the center, did not bother about their
environment (Fig. 1d). The stereotypy in JWM was
indicated by lower ambulation time (Fig. 2a) and distance
(Fig. 2b) than in the white mice.
Secretin considerably attenuated the stereotypic move-
ment. The circular movement of the animals was strikingly
reduced. It was also indicated by the difference in the
ambulation time and the ambulation distance. In untreated
JWM, it was nearly half of those than in white mice.
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Secretin did not influence these parameters in white mice;
however, it enhanced the ambulation time and the distance
in JWM to the level of CFLP white mice (Fig. 2a, b).
The analysis of vertical movements of the animals
showed that the white mice tried to explore their environ-
ment. This behavior was indicated by rearing and jumping.
They reared about 500 times during the 30-min examina-
tion period; however, JWM reared only nine times
(Fig. 3a). The white mice jumped up more than 100 times,
but the JWM only once during 30 min (Fig. 3b). Secretin
did not influence these two parameters in either group
(Fig. 3a, b).
Discussion
The regulation of the behavior of animals is very complex
process, many structures, neurotransmitters, and neuro-
peptides are involved in this mechanism. As it was
mentioned in the “Introduction” section, one of these
neuropeptides may be the secretin.
It was demonstrated nearly three decades ago that in rats,
icv administration of secretin decreased the open-field
locomotor activity and novel object approach (Charlton et
al. 1983). To better understand the neuroactive role of
secretin in the brain, Yamagata et al. (2008) recently
Figure 1 White lines in the panels demonstrate the horizontal
movement of a CFLP white mouse and a JW mouse detected by the
photosensors of the Conducta System. a The movement of CFLP
white mouse is basically linear. b JW mouse besides the linear, exhibit
circular movement indicated by loops. This phenomenon is pointed
out by white arrows. In a and b, the movement of animals was traced
for 1 min. c The white mouse tried to avoid the illuminated center of
the arena, she remained at the periphery. d However, the JW mouse
mainly resided in the center of the arena. The movement of the
animals in c and d was detected for 5 min
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generated secretin-deficient mice. LacZ reporter was intro-
duced in the secretin gene. In mutant mice, lacZ reporter
was demonstrated in the molecular layer of the hippocam-
pus, dentate gyrus, posterior commissure, habenula,
cerebellum, olfactory glomeruli, and the dorsal tegmentum.
No obvious morphological and developmental abnormali-
ties were found in the brain of these animals. Physiological
examination was only carried out in the hippocampus using
electrophysiological approach. A reduction in the long term-
potentiation (LTP) induction and LTPmaintenance was found.
These results suggest that both secretin and its receptor are
necessary for normal hippocampal function. The effect of
secretin is probably mediated through the glutamate, an
excitatory amino acid critical for LTP. This hypothesis is
supported by the findings of Kuntz et al. (2004) who
demonstrated that secretin increased GABA levels in the
rat hippocampus using microdialysis technique.
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Figure 3 Diagram shows the quantitative analysis of the vertical
movement of the animals (rearing and the jumping). a The white mice
reared more than 500 times during the 30 min-observation time but the
JWM reared only seven to nine times. b The white mice jumped up
about 150 times but the JWM only once during the observation period.
This difference was highly significant (***p<0.0001 control CFLP vs.
control JWM). Secretin did not influence these parameters in either
strain
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Figure 2 Diagram shows the quantitative analysis of the horizon-
tal movement of the animals; a demonstrates the ambulation time
and b the ambulation distance in both CFLP and JWM. In
untreated JWM, the ambulation time and distance were nearly half
of untreated white mice (*p<0.01 control CFLP vs. control JWM).
Secretin did not influence these two parameters in CFLP white
mice; however, in JWM, secretin significantly enhanced both
ambulation time and distance (#p<0.02 control JWM vs. secretin
JWM). These two parameters were even higher in secretin-treated
JWM than in white mice; however, this difference was not
statistically significant. Duration time of the observation was
30 min
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The effect of secretin may be also mediated via other
structures of the nervous system. Two important candi-
dates may be the amygdala and the BNST. It was
demonstrated previously that iv or icv administration of
secretin to male rats induced c-fos gene expression in
structures belonging to the limbic system including
amygdala and BNST (Goulet et al. 2003; Welch et al.
2003). The role of these two structures in the behavior of
animals is strongly suggested. It was recently demonstrat-
ed by Carty et al. (2010) that hypoxia induced by carotid
ligation in neonatal rats (on postnatal day 3) decreased the
number of CRH neurons in the central amygdala. In these
animals, the decreased number of CRH neurons was
inversely correlated with the locomotor activity and
explorative behavior in open-field test.
A lot of evidence suggests that activity of BNST
mediates fear, stress, and anxiety-like behavior in human
and animals as well. The excitotoxic lesion of BNST
blocked the anxiety behavior induced central administration
of CRH; however, the lesion of the central amygdala did
not influence the effect of CRH (Walker et al. 2009;
Hammack et al. 2009). With the use of tracing technique,
direct connection between the two structures was demon-
strated (Davis and Whalen 2001).
The role of the nigro-striatal mesolimbic dopaminergic
system in the hyperactive locomotor activity and stereotipic
movement is also suggested (Pycock and Marsden 1978).
Amphetamine, apomorphine, and LSD 25 can induce
hyperactive stereotypic movements acting on dopamine
and serotonin receptors (Jaton et al. 1981).
It is well known that the cerebellum coordinates the motor
activity of the organism. Both secretin and its receptors were
demonstrated by Yung et al. (2001, 2006). They also
demonstrated that secretin facilitated the GABA-ergic
inhibitory inputs onto Purkinje cells via a postsynaptic and
cAMP-dependent mechanism as a retrograde messenger. The
participation of the cerebellum in the stereotypic movements
was also suggested by Pierce and Courchesne (2001). They
observed with the use of magnetic resonance imaging that
the size of the VI. and VII. lobes of the cerebellar vermis is
negatively correlated with the seriousness of the repetitive
movements in autistic patients.
In this present work, we investigated the effect of
secretin on the locomotor activity and on the explorative
behavior in JWM and CFLP white mice. Our animal model,
JWM showed a repetitive circular movement, a stereotypic
behavior which also occurs in several mental disorders.
Secretin strikingly improved the stereotypy. The animals
exhibited more linear movement instead of circular one. In
the computerized analysis, it was indicated by the enhance-
ment of the ambulation time and distance during the
observation period. The secretin did not influence the
explorative behavior which was indicated by rearing and
jumping of animals. In our experimental conditions, none
of the parameters was influenced by secretin in the control
CFLP white mice.
The question arises how secretin can influence the
locomotor activity of JWM. Most likely, it acts through
structures where secretin receptors were demonstrated and
which are related to hyperactive movements. It is most
likely that the amygdala-BNST CRH-containing neuronal
circuits are responsible for this effect. The role of the nigro-
striatal system and the cerebellum is not excluded.
In summary, the data show that secretin influences the
locomotor activity of a special animal model. Its effect on
the repetitive movement is beneficial. It normalizes the
horizontal movement (ambulation time and distance),
although it does not improve the explorative behavior of
the animals.
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